Cargando…
Four Case Reports of Acute Psychosis Secondary to Low Doses of Prednisone/Prednisolone
Prednisone, the prodrug of prednisolone, has been implicated as the cause of neuropsychiatric symptoms such as depression, mania, agitation, delirium, dementia, psychosis, and many other affective, behavioral, and cognitive changes. Although the literature suggests that patients on 40 mg or more of...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801186/ https://www.ncbi.nlm.nih.gov/pubmed/35141097 http://dx.doi.org/10.7759/cureus.20853 |
_version_ | 1784642398687592448 |
---|---|
author | Lesko, Aquila Kalafat, Naciye Afreen, Maleeha |
author_facet | Lesko, Aquila Kalafat, Naciye Afreen, Maleeha |
author_sort | Lesko, Aquila |
collection | PubMed |
description | Prednisone, the prodrug of prednisolone, has been implicated as the cause of neuropsychiatric symptoms such as depression, mania, agitation, delirium, dementia, psychosis, and many other affective, behavioral, and cognitive changes. Although the literature suggests that patients on 40 mg or more of prednisone a day are at a greater risk for steroid-induced psychosis, patients on <40 mg are still at risk, and therefore, steroid-induced psychosis should not be excluded from the differential. Prednisone is the prodrug of prednisolone, and the two are comparable on a milligram (mg)-to-mg basis. Here are four case studies, three from the literature and one new, that demonstrate acute psychosis secondary to low-dose prednisone/prednisolone use. |
format | Online Article Text |
id | pubmed-8801186 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-88011862022-02-08 Four Case Reports of Acute Psychosis Secondary to Low Doses of Prednisone/Prednisolone Lesko, Aquila Kalafat, Naciye Afreen, Maleeha Cureus Psychiatry Prednisone, the prodrug of prednisolone, has been implicated as the cause of neuropsychiatric symptoms such as depression, mania, agitation, delirium, dementia, psychosis, and many other affective, behavioral, and cognitive changes. Although the literature suggests that patients on 40 mg or more of prednisone a day are at a greater risk for steroid-induced psychosis, patients on <40 mg are still at risk, and therefore, steroid-induced psychosis should not be excluded from the differential. Prednisone is the prodrug of prednisolone, and the two are comparable on a milligram (mg)-to-mg basis. Here are four case studies, three from the literature and one new, that demonstrate acute psychosis secondary to low-dose prednisone/prednisolone use. Cureus 2021-12-31 /pmc/articles/PMC8801186/ /pubmed/35141097 http://dx.doi.org/10.7759/cureus.20853 Text en Copyright © 2021, Lesko et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Psychiatry Lesko, Aquila Kalafat, Naciye Afreen, Maleeha Four Case Reports of Acute Psychosis Secondary to Low Doses of Prednisone/Prednisolone |
title | Four Case Reports of Acute Psychosis Secondary to Low Doses of Prednisone/Prednisolone |
title_full | Four Case Reports of Acute Psychosis Secondary to Low Doses of Prednisone/Prednisolone |
title_fullStr | Four Case Reports of Acute Psychosis Secondary to Low Doses of Prednisone/Prednisolone |
title_full_unstemmed | Four Case Reports of Acute Psychosis Secondary to Low Doses of Prednisone/Prednisolone |
title_short | Four Case Reports of Acute Psychosis Secondary to Low Doses of Prednisone/Prednisolone |
title_sort | four case reports of acute psychosis secondary to low doses of prednisone/prednisolone |
topic | Psychiatry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801186/ https://www.ncbi.nlm.nih.gov/pubmed/35141097 http://dx.doi.org/10.7759/cureus.20853 |
work_keys_str_mv | AT leskoaquila fourcasereportsofacutepsychosissecondarytolowdosesofprednisoneprednisolone AT kalafatnaciye fourcasereportsofacutepsychosissecondarytolowdosesofprednisoneprednisolone AT afreenmaleeha fourcasereportsofacutepsychosissecondarytolowdosesofprednisoneprednisolone |